SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:kth-26215"
 

Search: onr:"swepub:oai:DiVA.org:kth-26215" > SOX10 expression in...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

SOX10 expression in superficial spreading and nodular malignant melanomas

Agnarsdóttir, Margrét (author)
Uppsala universitet,Institutionen för genetik och patologi
Sooman, Linda (author)
Uppsala universitet,Enheten för onkologi
Bolander, Asa (author)
Uppsala universitet,Enheten för onkologi
show more...
Stromberg, Sara (author)
Uppsala universitet,Institutionen för genetik och patologi
Rexhepaj, Elton (author)
UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Ireland
Bergqvist, Michael (author)
Uppsala universitet,Enheten för onkologi
Pontén, Fredrik (author)
Uppsala universitet,Institutionen för genetik och patologi
Gallagher, William (author)
UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Ireland
Lennartsson, Johan (author)
Uppsala universitet,Ludwiginstitutet för cancerforskning
Ekman, Simon (author)
Uppsala universitet,Enheten för onkologi
Uhlen, Mathias (author)
KTH,Proteomik,Albanova VinnExcellence Center for Protein Technology, ProNova,Department of Proteomics, School of Biotechnology, AlbaNova University Center, KTH-Royal Institute of Technology, Stockholm, Sweden
Hedstrand, Håkan (author)
Uppsala universitet,Dermatologi och venereologi
show less...
 (creator_code:org_t)
2010
2010
English.
In: Melanoma research. - 0960-8931 .- 1473-5636. ; 20:6, s. 468-478
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • SOX10 is a transcription factor expressed in nerve cells and melanocytes. The aim of this study was to investigate the protein expression pattern of SOX10 in malignant melanoma tumors and to analyze whether the results correlated with clinical parameters and the proliferation marker Ki-67. Furthermore, proliferation and migration were analyzed in three different cell lines employing SOX10 small interfering RNA-mediated silencing. Expression patterns were determined in 106 primary tumors and 39 metastases in addition to 16 normal skin samples and six benign nevi employing immunohistochemistry and tissue microarrays. The immunohistochemical staining was evaluated manually and with an automated algorithm. SOX10 was strongly expressed in the benign tissues, but for the malignant tumors superficial spreading melanomas stained stronger than nodular malignant melanomas (P = 0.008). The staining intensity was also inversely correlated with T-stage (Spearman's rho = -0.261, P = 0.008). Overall survival and time to recurrence were significantly correlated with SOX10 intensity, but not in multivariate analysis including T-stage. With the automated algorithm there was an inverse correlation between the SOX10 staining intensity and the proliferation marker, Ki-67 (rho = -0.173, P = 0.02) and a significant difference in the intensity signal between the benign tissues, the primary tumors and the metastases where the metastases stained the weakest (P <= 0.001). SOX10 downregulation resulted in variable effects on proliferation and migration rates in the melanoma cell lines. In conclusion, the SOX10 intensity level differed depending on the tissue studied and SOX10 might have a role in survival. No conclusion regarding the role of SOX10 for in-vitro proliferation and migration could be drawn. Melanoma Res 20:468-478

Subject headings

NATURVETENSKAP  -- Biologi -- Biokemi och molekylärbiologi (hsv//swe)
NATURAL SCIENCES  -- Biological Sciences -- Biochemistry and Molecular Biology (hsv//eng)

Keyword

immunohistochemistry
malignant melanoma
small interfering RNA
SOX10
Biochemistry
Biokemi
MEDICINE

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view